- Home
- SHIP vs SLS Comparison
SHIP vs SLS Comparison
Compare SHIP & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHIP
- SLS
- Stock Information
- Founded
- SHIP 2008
- SLS 2012
- Country
- SHIP Greece
- SLS United States
- Employees
- SHIP N/A
- SLS N/A
- Industry
- SHIP Marine Transportation
- SLS Biotechnology: Pharmaceutical Preparations
- Sector
- SHIP Consumer Discretionary
- SLS Health Care
- Exchange
- SHIP Nasdaq
- SLS Nasdaq
- Market Cap
- SHIP 154.3M
- SLS 165.6M
- IPO Year
- SHIP 2007
- SLS N/A
- Fundamental
- Price
- SHIP $7.29
- SLS $1.63
- Analyst Decision
- SHIP Strong Buy
- SLS Strong Buy
- Analyst Count
- SHIP 1
- SLS 1
- Target Price
- SHIP $11.00
- SLS $7.00
- AVG Volume (30 Days)
- SHIP 118.3K
- SLS 1.7M
- Earning Date
- SHIP 08-05-2025
- SLS 08-12-2025
- Dividend Yield
- SHIP 10.43%
- SLS N/A
- EPS Growth
- SHIP N/A
- SLS N/A
- EPS
- SHIP 0.73
- SLS N/A
- Revenue
- SHIP $147,718,000.00
- SLS N/A
- Revenue This Year
- SHIP N/A
- SLS N/A
- Revenue Next Year
- SHIP $20.86
- SLS N/A
- P/E Ratio
- SHIP $10.01
- SLS N/A
- Revenue Growth
- SHIP 1.66
- SLS N/A
- 52 Week Low
- SHIP $4.78
- SLS $0.77
- 52 Week High
- SHIP $12.65
- SLS $2.27
- Technical
- Relative Strength Index (RSI)
- SHIP 57.41
- SLS 45.73
- Support Level
- SHIP $7.22
- SLS $1.50
- Resistance Level
- SHIP $7.50
- SLS $1.66
- Average True Range (ATR)
- SHIP 0.23
- SLS 0.10
- MACD
- SHIP 0.00
- SLS -0.00
- Stochastic Oscillator
- SHIP 59.60
- SLS 43.33
About SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Geniuship, Premiership, Squireship, And Friendship.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.